Cutaneous protothecosis in a patient on ustekinumab for psoriasis

被引：2
作者：
Jenkinson, Helena [1 ]
Thelin, Lindsay [2 ]
McAndrew, Rachel [3 ]
Jones, Krystal M. [3 ]
Talbott, L. Brent [4 ]
Diven, Dayna [3 ]
机构：
[1] Univ Texas Austin, Dell Med Sch, Dept Internal Med, 601 East 15th St, Austin, TX 78701 USA
[2] Confluence Hlth, Dept Dermatol, Wenatchee, WA USA
[3] Univ Texas Austin, Dept Dermatol, Dell Med Sch, Austin, TX 78712 USA
[4] Univ Texas Austin, Dept Pathol, Sch Med, Austin, TX 78712 USA
来源：
INTERNATIONAL JOURNAL OF DERMATOLOGY | 2018年 / 57卷 / 10期
关键词：
DISEASE;
D O I：
10.1111/ijd.13990
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：1246 / 1248
页数：3
相关论文
共 10 条
  • [1] CUTANEOUS MANIFESTATIONS OF PROTOTHECA INFECTIONS
    BOYD, AS
    LANGLEY, M
    KING, LE
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1995, 32 (05) : 758 - 764
  • [2] Cutaneous protothecosis: report of five cases
    Chao, SC
    Hsu, MML
    Lee, JYY
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2002, 146 (04) : 688 - 693
  • [3] Cutaneous protothecosis
    Cho, BK
    Ham, SH
    Lee, JY
    Choi, JH
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2002, 41 (05) : 304 - 306
  • [4] Ustekinumab in treatment of Crohn's disease: design, development, and potential place in therapy
    Deepak, Parakkal
    Loftus, Edward V., Jr.
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 3685 - 3698
  • [5] Long-term safety experience of ustekinumab in patients with moderate to severe psoriasis (Part II of II): Results from analyses of infections and malignancy from pooled phase II and III clinical trials
    Gordon, Kenneth B.
    Papp, Kim A.
    Langley, Richard G.
    Ho, Vincent
    Kimball, Alexa B.
    Guzzo, Cynthia
    Yeilding, Newman
    Szapary, Philippe O.
    Fakharzadeh, Steven
    Li, Shu
    Hsu, Ming-Chun
    Reich, Kristian
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (05) : 742 - 751
  • [6] Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis Results From the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
    Kalb, Robert E.
    Fiorentino, David F.
    Lebwohl, Mark G.
    Toole, John
    Poulin, Yves
    Cohen, Arnon D.
    Goyal, Kavitha
    Fakharzadeh, Steven
    Calabro, Stephen
    Chevrier, Marc
    Langholff, Wayne
    You, Yin
    Leonardi, Craig L.
    [J]. JAMA DERMATOLOGY, 2015, 151 (09) : 961 - 969
  • [7] Fatal case of protothecosis in a hematopoietic stem cell transplant recipient after infliximab treatment for graft-versus-host disease
    Khoury, JA
    Dubberke, ER
    Devine, SM
    [J]. BLOOD, 2004, 104 (10) : 3414 - 3415
  • [8] Human protothecosis
    Lass-Floerl, Cornelia
    Mayr, Astrid
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2007, 20 (02) : 230 - +
  • [9] Protothecosis in hematopoietic stem cell transplantation: case report and review of previous cases
    Macesic, N.
    Fleming, S.
    Kidd, S.
    Madigan, V.
    Chean, R.
    Ritchie, D.
    Slavin, M.
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2014, 16 (03) : 490 - 495
  • [10] IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases
    Teng, Michele W. L.
    Bowman, Edward P.
    McElwee, Joshua J.
    Smyth, Mark J.
    Casanova, Jean-Laurent
    Cooper, Andrea M.
    Cua, Daniel J.
    [J]. NATURE MEDICINE, 2015, 21 (07) : 719 - 729
1